134 related articles for article (PubMed ID: 19147277)
21. Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells.
Shimizu M; Suzui M; Deguchi A; Lim JT; Weinstein IB
Clin Cancer Res; 2004 Feb; 10(3):1130-40. PubMed ID: 14871993
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
23. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T
Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155
[TBL] [Abstract][Full Text] [Related]
24. The estrogen-responsive B box protein: a novel regulator of keratinocyte differentiation.
Beer HD; Munding C; Dubois N; Mamie C; Hohl D; Werner S
J Biol Chem; 2002 Jun; 277(23):20740-9. PubMed ID: 11919186
[TBL] [Abstract][Full Text] [Related]
25. A molecular basis for retinoic acid-induced axial truncation.
Iulianella A; Beckett B; Petkovich M; Lohnes D
Dev Biol; 1999 Jan; 205(1):33-48. PubMed ID: 9882496
[TBL] [Abstract][Full Text] [Related]
26. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
27. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition.
Afonja O; Raaka BM; Huang A; Das S; Zhao X; Helmer E; Juste D; Samuels HH
Oncogene; 2002 Nov; 21(51):7850-60. PubMed ID: 12420222
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitors regulate retinoic acid receptor beta expression in neuroblastoma cells by both transcriptional and posttranscriptional mechanisms.
De los Santos M; Zambrano A; Sánchez-Pacheco A; Aranda A
Mol Endocrinol; 2007 Oct; 21(10):2416-26. PubMed ID: 17622583
[TBL] [Abstract][Full Text] [Related]
29. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
30. All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor- dependent signaling pathway.
Lee HY; Dohi DF; Kim YH; Walsh GL; Consoli U; Andreeff M; Dawson MI; Hong WK; Kurie JM
J Clin Invest; 1998 Mar; 101(5):1012-9. PubMed ID: 9486971
[TBL] [Abstract][Full Text] [Related]
31. Retinoid, retinoic acid receptor beta and breast cancer.
Yang Q; Sakurai T; Kakudo K
Breast Cancer Res Treat; 2002 Nov; 76(2):167-73. PubMed ID: 12452454
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of histone H3 is functionally linked to retinoic acid receptor beta promoter activation.
Lefebvre B; Ozato K; Lefebvre P
EMBO Rep; 2002 Apr; 3(4):335-40. PubMed ID: 11897660
[TBL] [Abstract][Full Text] [Related]
33. Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines.
Suh YA; Lee HY; Virmani A; Wong J; Mann KK; Miller WH; Gazdar A; Kurie JM
Cancer Res; 2002 Jul; 62(14):3945-9. PubMed ID: 12124324
[TBL] [Abstract][Full Text] [Related]
34. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression.
Kwon HS; Huang B; Ho Jeoung N; Wu P; Steussy CN; Harris RA
Biochim Biophys Acta; 2006; 1759(3-4):141-51. PubMed ID: 16757381
[TBL] [Abstract][Full Text] [Related]
35. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
Crowe DL; Shuler CF
Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition.
Soprano DR; Chen LX; Wu S; Donigan AM; Borghaei RC; Soprano KJ
Oncogene; 1996 Feb; 12(3):577-84. PubMed ID: 8637715
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
[TBL] [Abstract][Full Text] [Related]
39. Role of the histone deacetylase complex in acute promyelocytic leukaemia.
Lin RJ; Nagy L; Inoue S; Shao W; Miller WH; Evans RM
Nature; 1998 Feb; 391(6669):811-4. PubMed ID: 9486654
[TBL] [Abstract][Full Text] [Related]
40. Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid.
Wu S; Zhang ZP; Zhang D; Soprano DR; Soprano KJ
Exp Cell Res; 1997 Nov; 237(1):118-26. PubMed ID: 9417874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
